PBS updates

Vitrakvi (Larotrectinib)

larotrectinib 100 mg capsule, 56 · ORAL · PBS code 13043L

AUTHORITY_REQUIRED

What it costs

AU$9900 PBS-determined price per 56 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

  • • First listed on the PBS: 2022-07-01.
  • • Repeats: 5.
  • • PBS program: GE.
Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Solid tumours with confirmed neurotrophic tropomyosin receptor kinase (NTRK) gene fusion


Continuing treatment


Patient must be undergoing continuing PBS-subsidised treatment commenced through an 'Initial treatment' listing for solid tumours (of any type) with confirmed NTRK gene fusion where treatment with this drug is/was initiated in a child; or

Patient must be undergoing continuing PBS-subsidised treatment commenced through an 'Initial treatment' listing for solid tumours (of certain specified types) with confirmed NTRK gene fusion which either includes: (i) mammary analogue secretory carcinoma of the salivary gland, (ii) secretory breast carcinoma; AND

The treatment must cease to be a PBS benefit upon radiographic progression; AND

The treatment must be the sole PBS-subsidised systemic anti-cancer therapy for this condition.

Where radiographic progression is observed, mark any remaining repeat prescriptions with the word 'cancelled'.

Sponsor: Bayer Australia Ltd ABN 22 000 138 714

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.